Howard Welgus

Title: Howard Welgus: Innovator in Pharmaceutical Formulations

Introduction

Howard Welgus is a notable inventor based in Ballwin, Missouri, recognized for his contributions to the field of pharmaceuticals. He has developed a unique method aimed at improving patient compliance by reducing side effects associated with certain medications.

Latest Patents

Welgus holds a patent for a method designed to reduce side effects from the administration of phosphodiesterase-4 inhibitors. This innovative approach involves altering the pharmacokinetic profile of a pharmaceutical formulation containing a PDE-4 inhibitor, such as roflumilast. By topically administering the PDE-4 inhibitor in combination with one or more phosphate ester surfactants, the spike in Cmax is significantly reduced. This reduction leads to fewer gastrointestinal side effects, ultimately enhancing patient compliance.

Career Highlights

Welgus is currently employed at Arcutis Biotherapeutics, Inc., where he continues to work on advancing pharmaceutical technologies. His expertise in the field has made him a valuable asset to the company and the industry at large.

Collaborations

One of his notable coworkers is David W. Osborne, with whom he collaborates on various projects aimed at improving drug formulations and patient outcomes.

Conclusion

Howard Welgus is a distinguished inventor whose work in pharmaceutical formulations has the potential to significantly improve patient experiences with medications. His innovative methods reflect a commitment to enhancing healthcare through scientific advancements.